Cacna1aem1(IMPC)H/Cacna1a+
C57BL/6NTac-Cacna1aem1(IMPC)H/H
|
increased freezing behavior |
J:211773
|
Cacna1aem1(IMPC)H/Cacna1aem1(IMPC)H
C57BL/6NTac-Cacna1aem1(IMPC)H/H
|
preweaning lethality, incomplete penetrance |
J:211773
|
Cacna1aem1Andm/Cacna1aem1Andm
C57BL/6J-Cacna1aem1Andm
|
ataxia |
J:338850
|
Cacna1am1Btlr/Cacna1am1Btlr
C57BL/6J-Cacna1am1Btlr
|
impaired balance |
J:267668
|
impaired coordination |
J:267668
|
Cacna1arkr/Cacna1arkr
B6.Cg-Cacna1arkr
|
abnormal gait |
J:71860
|
abnormal locomotor coordination |
J:71860
|
abnormal Purkinje cell dendrite morphology |
J:71860
|
absence seizures |
J:71860
|
ataxia |
J:71860
|
tremors |
J:71860
|
Cacna1asmrl/Cacna1asmrl
CXB10/HiAJ-Cacna1asmrl/GrsrJ
|
abnormal motor coordination/balance |
J:198844
|
abnormal survival |
J:198844
|
ataxia |
J:198844
|
decreased litter size |
J:198844
|
decreased survivor rate |
J:198844
|
impaired balance |
J:198844
|
impaired limb coordination |
J:198844
|
impaired righting response |
J:198844
|
neonatal lethality, incomplete penetrance |
J:198844
|
perinatal lethality, incomplete penetrance |
J:198844
|
normal
vision/eye phenotype |
J:198844
|
Cacna1atg-4J/Cacna1atg-4J
B6.C3Bir-Cacna1atg-4J
|
abnormal motor capabilities/coordination/movement |
J:137816
|
abnormal nervous system electrophysiology |
J:137816
|
abnormal Purkinje cell axon morphology |
J:137816
|
abnormal Purkinje cell dendrite morphology |
J:137816
|
absence seizures |
J:137816
|
ataxia |
J:137816
|
decreased Purkinje cell size |
J:137816
|
Cacna1aTg-5J/Cacna1a+
B10.Cg-Cacna1aTg-5J
|
abnormal axon morphology |
J:137816
|
abnormal nervous system electrophysiology |
J:137816
|
abnormal Purkinje cell dendrite morphology |
J:137816
|
abnormal Purkinje cell morphology |
J:137816
|
ataxia |
J:137816
|
Cacna1aTg-5J/Cacna1a+ Tg(Pvalb-EGFP)B20Zjh/?
involves: BALB/cByJ * C57BL/6 * C57BL/10J
|
abnormal Purkinje cell morphology |
J:137816
|
Cacna1aTg-5J/Cacna1aTg-5J
B10.Cg-Cacna1aTg-5J
|
preweaning lethality, complete penetrance |
J:137816
|
Cacna1aTg-5J/Cacna1aTg-5J
involves: BALB/cByJ * C57BL/10J
|
ataxia |
J:137816
|
decreased body size |
J:137816
|
premature death |
J:137816
|
preweaning lethality, incomplete penetrance |
J:137816
|
Cacna1atg-6J/Cacna1atg-6J
involves: BALB/cByJ * C57BL/6J
|
abnormal spleen red pulp morphology |
J:82238
|
decreased body size |
J:82238
|
decreased bone marrow cell number |
J:82238
|
impaired limb coordination |
J:82238
|
limb grasping |
J:82238
|
thymus atrophy |
J:82238
|
Cacna1aTg-7J/Cacna1a+
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal gait |
J:161271
|
ataxia |
J:161271
|
Cacna1atg-la/Cacna1a+
involves: AKR/J * C3H/HeJ * C57BL/6J
|
normal
behavior/neurological phenotype |
J:119639
|
Cacna1atg-la/Cacna1atg-la
B6.Cg-Os +/+ Cacna1atg-la/J
|
abnormal action potential |
J:72853
|
abnormal channel response |
J:72853
|
abnormal nerve fiber response |
J:72853
|
decreased nerve fiber response intensity |
J:72853
|
decreased thermal nociceptive threshold |
J:72853
|
hyporesponsive to tactile stimuli |
J:72853
|
normal
nervous system phenotype |
J:72853
|
Cacna1atg-la/Cacna1aWb
involves: AKR/J * C3H/HeJ * C57BL/6J
|
ataxia |
J:119639
|
decreased grip strength |
J:119639
|
dystonia |
J:119639
|
impaired coordination |
J:119639
|
Cacna1atg-rol/Cacna1a+
involves: C3Hf/Nga * C57BL/6 * SIII
|
abnormal glucose homeostasis |
J:3611
|
abnormal nervous system physiology |
J:3611
|
Cacna1atg-rol/Cacna1atg-rol
involves: C3Hf/Nga * C57BL/6 * SIII
|
abnormal glucose homeostasis |
J:3611
|
abnormal nervous system physiology |
J:3611
|
decreased body weight |
J:3611
|
increased noradrenaline level |
J:164122
|
small cerebellum |
J:164122
|
Cacna1atg-rol/Cacna1atg-rol
involves: C57BL/6 * SIII
|
abnormal brainstem morphology |
J:6553
|
abnormal cerebellum morphology |
J:12735,
J:107924
|
abnormal CNS synaptic transmission |
J:109231
|
abnormal excitatory postsynaptic currents |
J:109231
|
abnormal metabolism |
J:15508
|
abnormal miniature excitatory postsynaptic currents |
J:109231
|
abnormal muscle electrophysiology |
J:164115
|
abnormal nursing |
J:12735
|
abnormal response/metabolism to endogenous compounds |
J:15508
|
ataxia |
J:12735,
J:109231
|
cerebellum atrophy |
J:107924
|
cerebellum hypoplasia |
J:15016
|
decreased choline O-acetyltransferase activity |
J:6553
|
decreased glutamic acid level |
J:6553
|
enhanced paired-pulse facilitation |
J:109231
|
impaired limb coordination |
J:12735
|
increased apoptosis |
J:107924
|
increased brain tyrosine 3-monooxygenase activity |
J:6553
|
increased glycine level |
J:6553
|
increased taurine level |
J:6553
|
normal
mortality/aging |
J:15016
|
muscle weakness |
J:164115
|
prolonged excitatory postsynaptic current decay time |
J:164115
|
reduced female fertility |
J:12735
|
reduced male fertility |
J:12735
|
small cerebellum |
J:6553
|
weakness |
J:12735
|
Cacna1atg-rol/Cacna1atg
involves: C3H * C57BL/6 * DBA/2J * SIII
|
abnormal gait |
J:14882
|
abnormal locomotor behavior |
J:14882
|
abnormal nervous system morphology |
J:14882
|
ataxia |
J:14882
|
normal
behavior/neurological phenotype |
J:14882
|
normal
mortality/aging |
J:14882
|
Cacna1atg/Cacna1atg
B6.D2-Cacna1atg/J
|
abnormal gait |
J:6154
|
abnormal muscle electrophysiology |
J:233263
|
abnormal nervous system electrophysiology |
J:6154
|
abnormal paired-pulse inhibition |
J:109231
|
ataxia |
J:109231
|
decreased body weight |
J:6154
|
decreased excitatory postsynaptic current amplitude |
J:109231
|
dystonia |
J:233263
|
increased susceptibility to pharmacologically induced seizures |
J:6154
|
seizures |
J:6154
|
Cacna1atg/Cacna1atg
involves: 101 * C3H * C57BL/10 * DBA/2J
|
abnormal gait |
J:262
|
abnormal maternal nurturing |
J:262
|
abnormal motor capabilities/coordination/movement |
J:262
|
abnormal posture |
J:262
|
impaired limb coordination |
J:262
|
impaired swimming |
J:262
|
reduced fertility |
J:262
|
seizures |
J:262
|
sporadic seizures |
J:262
|
Cacna1atg/Cacna1atg
involves: C57BL/6J * DBA/2J
|
abnormal CNS synaptic transmission |
J:106959
|
abnormal nervous system physiology |
J:221681
|
abnormal somatosensory cortex physiology |
J:221681
|
abnormal synaptic transmission |
J:221681
|
Cacna1atg/Cacna1atg
involves: DBA/2J
|
abnormal gait |
J:262
|
infertility |
J:262
|
Cacna1atg/Cacna1atg
involves: DBA/2J * C57BL/10JGn
|
abnormal gait |
J:262
|
Cacna1atg/Cacna1atm2.1Maag
involves: 129P2/OlaHsd * C57BL/6J * DBA/2J * FVB/N
|
abnormal muscle electrophysiology |
J:233263
|
dystonia |
J:233263
|
Cacna1atg/Cacna1atm2.1Maag Tg(Pcp2-cre)2Mpin/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2J * FVB/N
|
dystonia |
J:233263
|
Cacna1atm1.1Ehess/Cacna1atm1.1Ehess
C57BL/6-Cacna1atm1.1Ehess
|
abnormal channel response |
J:217557
|
normal
behavior/neurological phenotype |
J:217557
|
Cacna1atm1.1Ehess/Cacna1atm2.1Maag Tg(Atoh1-cre/Esr1*)14Fsh/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
normal
behavior/neurological phenotype |
J:217557
|
Cacna1atm1.1Ehess/Cacna1atm2.1Maag Tg(Pcp2-cre)2Mpin/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
behavior/neurological phenotype |
J:217557
|
Cacna1atm1.1Sher/Cacna1atm1.1Sher
involves: 129S4/SvJae
|
no abnormal phenotype detected |
J:170451
|
Cacna1atm1.1Sher/Cacna1atm1.1Sher Tg(Pcp2-cre)2Mpin/0
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ
|
abnormal action potential |
J:170451
|
abnormal channel response |
J:170451
|
abnormal inhibitory postsynaptic currents |
J:170451
|
abnormal seizure response to inducing agent |
J:170451
|
abnormal spike wave discharge |
J:170451
|
absence seizures |
J:170451
|
ataxia |
J:170451
|
decreased body weight |
J:170451
|
decreased grip strength |
J:170451
|
environmentally induced seizures |
J:170451
|
impaired coordination |
J:170451
|
small cerebellum |
J:170451
|
thin cerebellar granule layer |
J:170451
|
thin cerebellar molecular layer |
J:170451
|
Cacna1atm1.2Sher/Cacna1atm1.2Sher
involves: 129S4/SvJae
|
abnormal inhibitory postsynaptic currents |
J:170451
|
ataxia |
J:170451
|
decreased body size |
J:170451
|
premature death |
J:170451
|
seizures |
J:170451
|
Cacna1atm1Fcr/Cacna1atm1Fcr
involves: 129S1/Sv * C57BL/6J
|
abnormal brain morphology |
J:76459
|
abnormal motor capabilities/coordination/movement |
J:76459
|
abnormal nervous system physiology |
J:76459
|
abnormal postnatal growth/weight/body size |
J:76459
|
premature death |
J:76459
|
Cacna1atm1Hssh/Cacna1atm1Hssh
involves: 129 * C57BL/6J
|
abnormal axon morphology |
J:59076
|
abnormal cerebellum external granule cell layer morphology |
J:59076
|
abnormal channel response |
J:59076
|
abnormal excitatory postsynaptic potential |
J:59076
|
abnormal neuron morphology |
J:59076
|
ataxia |
J:59076
|
decreased body size |
J:59076
|
impaired balance |
J:59076
|
impaired righting response |
J:59076
|
muscle spasm |
J:59076
|
premature death |
J:59076
|
small cerebellum |
J:59076
|
Cacna1atm1Hssh/Cacna1atm1Hssh
involves: C57BL/6J
|
abnormal brain wave pattern |
J:59076
|
abnormal channel response |
J:59076
|
abnormal CNS synaptic transmission |
J:59076
|
abnormal spike wave discharge |
J:59076
|
Cacna1atm1Hssh/Cacna1atm1Hssh
Not Specified
|
abnormal excitatory postsynaptic currents |
J:173318
|
abnormal synapse morphology |
J:173318
|
Cacna1atm1Hzo/Cacna1atm1Hzo
involves: 129S/SvEv
|
abnormal channel response |
J:139488
|
normal
behavior/neurological phenotype |
J:139488
|
Cacna1atm1Kano/Cacna1atm1Kano Grid2tm1(cre)Mwa/Grid2+
involves: C57BL/6 * C57BL/6N
|
abnormal CNS synaptic transmission |
J:173318
|
abnormal excitatory postsynaptic currents |
J:173318
|
abnormal neuron morphology |
J:173318
|
prolonged excitatory postsynaptic current decay time |
J:173318
|
prolonged excitatory postsynaptic current rise time |
J:173318
|
Cacna1atm1Kano/Cacna1atm1Kano Grid2tm1(cre)Mwa/Grid2+
involves: C57BL/6N
|
abnormal cerebellar molecular layer |
J:180582
|
abnormal excitatory postsynaptic current amplitude |
J:180582
|
abnormal Purkinje cell dendrite morphology |
J:180582
|
abnormal Purkinje cell morphology |
J:180582
|
increased neurotransmitter release |
J:180582
|
Purkinje cell degeneration |
J:180582
|
small cerebellum |
J:180582
|
Cacna1atm1Kano/Cacna1atm1Kano Grin2ctm2(icre)Mwa/Grin2c+
involves: C57BL/6N
|
normal
nervous system phenotype |
J:180582
|
Cacna1atm1Lory/Cacna1a+
involves: C57BL/6 * C57BL/6J
|
abnormal action potential |
J:258570
|
abnormal cerebellar molecular layer |
J:258570
|
abnormal excitatory postsynaptic currents |
J:258570
|
abnormal Purkinje cell dendrite morphology |
J:258570
|
abnormal Purkinje cell innervation |
J:258570
|
abnormal synapse morphology |
J:258570
|
absence seizures |
J:258570
|
ataxia |
J:258570
|
decreased excitatory postsynaptic current amplitude |
J:258570
|
decreased grip strength |
J:258570
|
decreased locomotor activity |
J:258570
|
decreased vertical activity |
J:258570
|
impaired coordination |
J:258570
|
increased cerebellar granule cell number |
J:258570
|
increased excitatory postsynaptic current amplitude |
J:258570
|
Cacna1atm1Lory/Cacna1atm1Lory
involves: C57BL/6 * C57BL/6J
|
postnatal lethality, complete penetrance |
J:258570
|
Cacna1atm1Maag/Cacna1a+
B6.129P2-Cacna1atm1Maag
|
abnormal nervous system electrophysiology |
J:144701
|
abnormal physiological response to xenobiotic |
J:144701
|
Cacna1atm1Maag/Cacna1atm1Maag
B6.129P2-Cacna1atm1Maag
|
abnormal nervous system electrophysiology |
J:144701
|
abnormal physiological response to xenobiotic |
J:144701
|
abnormal posture |
J:144701
|
circling |
J:144701
|
enhanced behavioral response to xenobiotic |
J:144701
|
hemiplegia |
J:144701
|
increased cerebral infarct size |
J:193793
|
increased susceptibility to ischemic brain injury |
J:193793
|
Cacna1atm1Maag/Cacna1atm1Maag
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal channel response |
J:88693
|
abnormal CNS synaptic transmission |
J:88693
|
abnormal miniature endplate potential |
J:88693
|
abnormal PNS synaptic transmission |
J:88693
|
abnormal synaptic acetylcholine release |
J:88693
|
Cacna1atm1Nobs/Cacna1atm1Nobs
involves: 129 * C57BL/6J
|
abnormal motor capabilities/coordination/movement |
J:155607
|
ataxia |
J:155607
|
premature death |
J:155607
|
Cacna1atm1Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
|
abnormal motor capabilities/coordination/movement |
J:155607
|
absence seizures |
J:155607
|
ataxia |
J:155607
|
postnatal lethality, complete penetrance |
J:155607
|
Cacna1atm2(CACNA1A)Ttan/Cacna1atm2(CACNA1A)Ttan
involves: 129S4/SvJae
|
lethality at weaning, complete penetrance |
J:123243
|
Cacna1atm2.1(CACNA1A)Ttan/Cacna1atm2.1(CACNA1A)Ttan
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL
|
ataxia |
J:123243
|
dystonia |
J:123243
|
lethality at weaning, complete penetrance |
J:123243
|
Cacna1atm2.1Maag/Cacna1atm2.1Maag
involves: 129P2/OlaHsd
|
no abnormal phenotype detected |
J:117062
|
Cacna1atm2.1Maag/Cacna1atm2.1Maag Tg(Pcp2-cre)2Mpin/0
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
|
abnormal brain interneuron morphology |
J:234599
|
abnormal cerebellar granule cell morphology |
J:234599
|
abnormal cerebellar molecular layer |
J:234599
|
abnormal cerebellum morphology |
J:234599
|
ataxia |
J:234599
|
impaired balance |
J:234599
|
impaired coordination |
J:234599
|
impaired righting response |
J:234599
|
Purkinje cell degeneration |
J:234599
|
tremors |
J:234599
|
Cacna1atm2.1Maag/Cacna1atm2.2Maag Tg(EIIa-cre)C5379Lmgd/0
involves: 129P2/OlaHsd * FVB/N
|
abnormal synaptic acetylcholine release |
J:117062
|
ataxia |
J:117062
|
decreased body size |
J:117062
|
decreased neurotransmitter release |
J:117062
|
dystonia |
J:117062
|
lethality at weaning, complete penetrance |
J:117062
|
Cacna1atm2Hzo/Cacna1atm2Hzo
involves: 129S/SvEv
|
abnormal channel response |
J:139488
|
normal
behavior/neurological phenotype |
J:139488
|
Cacna1atm2Nobs/Cacna1atm2Nobs
involves: 129 * C57BL/6J
|
abnormal spike wave discharge |
J:155607
|
absence seizures |
J:155607
|
ataxia |
J:155607
|
cerebellum atrophy |
J:155607
|
clonic seizures |
J:155607
|
impaired coordination |
J:155607
|
normal
mortality/aging |
J:155607
|
Cacna1atm3Hzo/Cacna1a+
involves: 129S/SvEv * C57BL/6J
|
impaired coordination |
J:139488
|
Cacna1atm3Hzo/Cacna1atm3Hzo
B6.129S7-Cacna1atm3Hzo/J
|
impaired balance |
J:239981
|
impaired coordination |
J:239981
|
Purkinje cell degeneration |
J:239981
|
thin cerebellar molecular layer |
J:239981
|
Cacna1atm3Hzo/Cacna1atm3Hzo
involves: 129S/SvEv
|
abnormal channel response |
J:139488
|
abnormal neuron morphology |
J:139488
|
abnormal Purkinje cell morphology |
J:190729
|
decreased locomotor activity |
J:139488
|
disheveled coat |
J:139488
|
impaired coordination |
J:139488
|
normal
nervous system phenotype |
J:139488
|
Cacna1atm3Maag/Cacna1a+
B6.129P2-Cacna1atm3Maag
|
abnormal nervous system electrophysiology |
J:144701
|
abnormal physiological response to xenobiotic |
J:144701
|
enhanced behavioral response to xenobiotic |
J:144701
|
Cacna1atm3Maag/Cacna1a+
involves: 129P2/OlaHsd
|
increased cerebral infarct size |
J:193793
|
increased susceptibility to induced morbidity/mortality |
J:193793
|
increased susceptibility to ischemic brain injury |
J:193793
|
Cacna1atm3Maag/Cacna1atm3Maag
B6.129P2-Cacna1atm3Maag
|
abnormal nervous system electrophysiology |
J:144701
|
abnormal physiological response to xenobiotic |
J:144701
|
abnormal posture |
J:144701
|
circling |
J:144701
|
enhanced behavioral response to xenobiotic |
J:144701
|
hemiplegia |
J:144701
|
impaired coordination |
J:144701
|
increased susceptibility to xenobiotic induced morbidity/mortality |
J:144701
|
respiratory failure |
J:144701
|
seizures |
J:144701
|
Cacna1atm3Maag/Cacna1atm3Maag
involves: 129P2/OlaHsd
|
increased cerebral infarct size |
J:193793
|
increased susceptibility to induced morbidity/mortality |
J:193793
|
increased susceptibility to ischemic brain injury |
J:193793
|
Cacna1aWb/Cacna1a+
either: C3.B6-Cacna1aWb or (involves: C3H/HeJ * C57BL/6J)
|
ataxia |
J:119639
|
normal
behavior/neurological phenotype |
J:119639
|
cerebellum atrophy |
J:119639
|
decreased locomotor activity |
J:119639
|
normal
growth/size/body region phenotype |
J:119639
|
impaired coordination |
J:119639
|
normal
mortality/aging |
J:119639
|
normal
nervous system phenotype |
J:119639
|
thin cerebellar molecular layer |
J:119639
|
Cacna1aWb/Cacna1aWb
either: C3.B6-Cacna1aWb or (involves: C3H/HeJ * C57BL/6J)
|
ataxia |
J:119639
|
normal
behavior/neurological phenotype |
J:119639
|
cerebellum atrophy |
J:119639
|
decreased body size |
J:119639
|
decreased grip strength |
J:119639
|
dystonia |
J:119639
|
impaired coordination |
J:119639
|
impaired righting response |
J:119639
|
normal
nervous system phenotype |
J:119639
|
premature death |
J:119639
|
thin cerebellar molecular layer |
J:119639
|